Novel treatments targeting immune‐related mechanisms in primary biliary cholangitis
Author(s): ,
Marco Carbone
Affiliations:
Liver Unit, Humanitas Clinical and Research Institute, Rozzano (Milan), Italy. Academic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom
Pietro Invernizzi
Affiliations:
Program for Autoimmune Liver Diseases, International Center for Digestive Health, Department of Medicine and Surgery, University of Milan‐Bicocca, Milan, Italy. Division of Rheumatology, Allergy, and Clinical Immunology, University of California at Davis School of Medicine, Davis
Pietro Invernizzi, M.D., Ph.D., Associate Professor of Gastroenterology, Director of the Program for Autoimmune Liver Diseases, International Center for Digestive Health, Department of Medicine and Surgery, University of Milan‐Bicocca, Via Cadore 48, 20
AASLD LiverLearning®. Invernizzi P. Nov 30, 2016; 164849
Dr. Pietro Invernizzi
Dr. Pietro Invernizzi
Login now to access Regular content available to all registered users.

AASLD Members enjoy free LiverLearning® Premium Access. Registrants of The Liver Meeting® receive LiverLearning® Premium Access for one year from the first day of the meeting. A LiverLearning® Subscription ($150.00 US) grants access to LiverLearning® Premium content for one year after date of purchase. Click here to purchase your Premium Access Subscription now.


Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions